or
forgot password

    • cancer clinical trials in paris, TX

    • PhII ICb With/Without Erbitux in MBC Pts
    Paris Regional Cancer Center
    Paris, Texas 75460
    Metastatic Breast Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Paris Regional Cancer Center
    Paris, Texas 75460
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Paris Regional Cancer Center
    Paris, Texas 75460
    Breast Cancer
    Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
    Paris Regional Cancer Center
    Paris, Texas 75460
    Metastatic Gastric or GEJ Cancer
    Pre-op Rectal ChemoRad +/- Cetuximab
    Paris Regional Cancer Center
    Paris, Texas 75460
    Rectal Cancer
    Phase II Sunitinib Prog Met AIPC
    Paris Regional Cancer Center
    Paris, Texas 75460
    Metastatic Prostate Cancer
    Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
    Paris Regional Cancer Center
    Paris, Texas 75460
    Androgen-independent Prostate Cancer
    Ixabepilone + Carboplatin Metastatic Breast Cancer
    Paris Regional Cancer Center
    Paris, Texas 75460
    Metastatic Breast Cancer
    Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    US Oncology - Texas Oncology - Paris
    Paris, Texas 75460-5004
    Chronic Lymphocytic Leukemia
    Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer
    Texas Oncology-Paris
    Paris, Texas 75460
    Estrogen Receptor Positive Tumor, Breast Cancer
    Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
    Paris Regional Cancer Center
    Paris, Texas 75460
    Carcinoma, Non-Small-Cell Lung
    Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
    Paris Regional Cancer Center
    Paris, Texas 75460
    Colorectal Cancer Metastatic
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Paris Regional Cancer Center
    Paris, Texas 75460
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Paris Regional Cancer Center
    Paris, Texas 75460
    Metastatic Breast Cancer
    Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
    Paris Regional Cancer Center Lab
    Paris, Texas 75460
    Metastatic Breast Cancer